June 04, 2020 Targovax enters collaboration with Leidos to add checkpoint inhibitor functionality to ONCOS viruses
June 03, 2020 Aprea Therapeutics Completes Full Enrollment of Phase 3 Clinical Trial in TP53 Mutant Myelodysplastic Syndromes (MDS)
June 02, 2020 Nordic Nanovector to Present at Upcoming Jefferies Virtual Healthcare Conference and ABG Sundal Collier Virtual Oncology Seminar
June 01, 2020 Vivet’s Second Gene Therapy Product, VTX-803 for PFIC3, Receives US and European Orphan Drug Designation
June 01, 2020 New analysis confirms that multiple myeloma patients in the OCEAN study stay on treatment longer than previously estimated – results expected H1-2021
May 29, 2020 LifeArc awards £ 1.5 million grant to Vicore Pharma for the VP01 COVID-19 clinical study